Preexisting Adenovirus Seropositivity Is Not Associated With Increased HIV-1 Acquisition in Three HIV-1 Vaccine Efficacy Trials

od Stephenson, Kathryn E., Hural, John, Buchbinder, Susan P., Sinangil, Faruk, Barouch, Dan H.
Wydane 2012

Phylodynamics of HIV-1 from a Phase-III AIDS Vaccine Trial in North America

od Pérez-Losada, Marcos, Jobes, David V., Sinangil, Faruk, Crandall, Keith A., Posada, David, Berman, Phillip W.
Wydane 2010

Ethnic differences in the adaptation rate of HIV gp120 from a vaccine trial

od Pérez-Losada, Marcos, Posada, David, Arenas, Miguel, Jobes, David V, Sinangil, Faruk, Berman, Phillip W, Crandall, Keith A
Wydane 2009

Phylodynamics of HIV-1 from a Phase III AIDS Vaccine Trial in Bangkok, Thailand

od Pérez-Losada, Marcos, Jobes, David V., Sinangil, Faruk, Crandall, Keith A., Arenas, Miguel, Posada, David, Berman, Phillip W.
Wydane 2011

Novel Ring Structure in the gp41 Trimer of Human Immunodeficiency Virus Type 1 That Modulates Sensitivity and Resistance to Broadly Neutralizing Antibodies

od O'Rourke, Sara M., Schweighardt, Becky, Scott, William G., Wrin, Terri, Fonseca, Dora P. A. J., Sinangil, Faruk, Berman, Phillip W.
Wydane 2009

Comparative Immunogenicity of HIV-1 Clade C Envelope Proteins for Prime/Boost Studies

od Smith, Douglas H., Winters-Digiacinto, Peggy, Mitiku, Misrach, O'Rourke, Sara, Sinangil, Faruk, Wrin, Terri, Montefiori, David C., Berman, Phillip W.
Wydane 2010

Mutation at a Single Position in the V2 Domain of the HIV-1 Envelope Protein Confers Neutralization Sensitivity to a Highly Neutralization-Resistant Virus

od O'Rourke, Sara M., Schweighardt, Becky, Phung, Pham, Fonseca, Dora P. A. J., Terry, Karianne, Wrin, Terri, Sinangil, Faruk, Berman, Phillip W.
Wydane 2010

Cross-Subtype Neutralizing Antibodies Induced in Baboons by a Subtype E gp120 Immunogen Based on an R5 Primary Human Immunodeficiency Virus Type 1 Envelope

od VanCott, Thomas C., Mascola, John R., Loomis-Price, Lawrence D., Sinangil, Faruk, Zitomersky, Naamah, McNeil, John, Robb, Merlin L., Birx, Deborah L., Barnett, Susan
Wydane 1999

Induction of Neutralizing Antibodies to T-Cell Line-Adapted and Primary Human Immunodeficiency Virus Type 1 Isolates with a Prime-Boost Vaccine Regimen in Chimpanzees

od Zolla-Pazner, Susan, Lubeck, Michael, Xu, Serena, Burda, Sherri, Natuk, Robert J., Sinangil, Faruk, Steimer, Kathelyn, Gallo, Robert C., Eichberg, Jorg W., Matthews, Thomas, Robert-Guroff, Marjorie
Wydane 1998

Sequences in Glycoprotein gp41, the CD4 Binding Site, and the V2 Domain Regulate Sensitivity and Resistance of HIV-1 to Broadly Neutralizing Antibodies

od O'Rourke, Sara M., Schweighardt, Becky, Phung, Pham, Mesa, Kathryn A., Vollrath, Aaron L., Tatsuno, Gwen P., To, Briana, Sinangil, Faruk, Limoli, Kay, Wrin, Terri, Berman, Phillip W.
Wydane 2012

Longitudinal Population Analysis of Dual Infection with Recombination in Two Strains of HIV Type 1 Subtype B in an Individual from a Phase 3 HIV Vaccine Efficacy Trial

od JOBES, DAVID V., DAOUST, MELISSA, NGUYEN, VIVIAN T., PADUA, ALLAN, SINANGIL, FARUK, PÉREZ-LOSADA, MARCOS, CRANDALL, KEITH A., OLIPHANT, THEODORE, POSADA, DAVID, RAMBAUT, ANDREW, FUCHS, JONATHAN, BERMAN, PHILLIP W.
Wydane 2006

Functional Antibody Response Against V1V2 and V3 of HIV gp120 in the VAX003 and VAX004 Vaccine Trials

od Balasubramanian, Preetha, Williams, Constance, Shapiro, Mariya B., Sinangil, Faruk, Higgins, Keith, Nádas, Arthur, Totrov, Maxim, Kong, Xiang-Peng, Fiore-Gartland, Andrew J., Haigwood, Nancy L., Zolla-Pazner, Susan, Hioe, Catarina E.
Wydane w Sci Rep (2018)

Ancestral sequences from an elite neutralizer proximal to the development of neutralization resistance as a potential source of HIV vaccine immunogens

od Mesa, Kathryn A., Yu, Bin, Wrin, Terri, Petropoulos, Christos J., Pogson, Grant H., Alexander, David L., Perez, Gerardo, O’Rourke, Sara M., Sinangil, Faruk, Robinson, Joseph, Conant, Marcus A., Berman, Phillip W.
Wydane w PLoS One (2019)

Magnitude and breadth of a non-protective neutralizing antibody response in an efficacy trial of a candidate HIV-1 gp120 vaccine (AIDSVAX™ B/B)

od Gilbert, Peter, Wang, Maggie, Wrin, Terri, Petropoulos, Chris, Gurwith, Marc, Sinangil, Faruk, D'Souza, Patricia, Rodriguez-Chavez, Isaac R., DeCamp, Allan, Giganti, Mark, Berman, Phillip W., Self, Steve G., Montefiori, David C.
Wydane 2010

Vaccine Protection against a Heterologous, Non-Syncytium-Inducing, Primary Human Immunodeficiency Virus

od Robert-Guroff, Marjorie, Kaur, Harvinder, Patterson, L. Jean, Leno, Michel, Conley, Anthony J., McKenna, Philip M., Markham, Phillip D., Richardson, Ersell, Aldrich, Kristine, Arora, Kamalpreet, Murty, Lalita, Carter, Lucretia, Zolla-Pazner, Susan, Sinangil, Faruk
Wydane 1998

Differential Induction of Anti-V3 Crown Antibodies with Cradle- and Ladle-Binding Modes in Response to HIV-1 Envelope Vaccination

od Balasubramanian, Preetha, Kumar, Rajnish, Williams, Constance, Itri, Vincenza, Wang, Shixia, Lu, Shan, Hessell, Ann J., Haigwood, Nancy L., Sinangil, Faruk, Higgins, Keith W., Liu, Lily, Li, Liuzhe, Nyambi, Phillipe, Gorny, Miroslaw K., Totrov, Maxim, Nadas, Arthur, Kong, Xiang-Peng, Zolla-Pazner, Susan, Hioe, Catarina E.
Wydane w Vaccine (2017)

Comparison of Antibody Responses Induced by RV144, VAX003, and VAX004 Vaccination Regimens

od Karnasuta, Chitraporn, Akapirat, Siriwat, Madnote, Sirinan, Savadsuk, Hathairat, Puangkaew, Jiraporn, Rittiroongrad, Surawach, Rerks-Ngarm, Supachai, Nitayaphan, Sorachai, Pitisuttithum, Punnee, Kaewkungwal, Jaranit, Tartaglia, James, Sinangil, Faruk, Francis, Donald P., Robb, Merlin L., de Souza, Mark S., Michael, Nelson L., Excler, Jean-Louis, Kim, Jerome H., O'Connell, Robert J., Karasavvas, Nicos
Wydane w AIDS Res Hum Retroviruses (2017)

Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations

od Akapirat, Siriwat, Karnasuta, Chitraporn, Vasan, Sandhya, Rerks-Ngarm, Supachai, Pitisuttithum, Punnee, Madnote, Sirinan, Savadsuk, Hathairat, Rittiroongrad, Surawach, Puangkaew, Jiraporn, Phogat, Sanjay, Tartaglia, James, Sinangil, Faruk, de Souza, Mark S., Excler, Jean-Louis, Kim, Jerome H., Robb, Merlin L., Michael, Nelson L., Ngauy, Viseth, O'Connell, Robert J., Karasavvas, Nicos
Wydane w PLoS One (2018)

V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144

od Perez, Lautaro G., Martinez, David R., deCamp, Allan C., Pinter, Abraham, Berman, Phillip W., Francis, Donald, Sinangil, Faruk, Lee, Carter, Greene, Kelli, Gao, Hongmei, Nitayaphan, Sorachai, Rerks-Ngarm, Supachai, Kaewkungwal, Jaranit, Pitisuttithum, Punnee, Tartaglia, James, O’Connell, Robert J., Robb, Merlin L., Michael, Nelson L., Kim, Jerome H., Gilbert, Peter, Montefiori, David C.
Wydane w PLoS One (2017)

IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens

od Karasavvas, Nicos, Karnasuta, Chitraporn, Savadsuk, Hathairat, Madnote, Sirinan, Inthawong, Dutsadee, Chantakulkij, Somsak, Rittiroongrad, Surawach, Nitayaphan, Sorachai, Pitisuttithum, Punnee, Thongcharoen, Prasert, Siriyanon, Vinai, Andrews, Charla A., Barnett, Susan W., Tartaglia, James, Sinangil, Faruk, Francis, Donald P., Robb, Merlin L., Michael, Nelson L., Ngauy, Viseth, de Souza, Mark S., Paris, Robert M., Excler, Jean-Louis, Kim, Jerome H., O'Connell, Robert J.
Wydane w AIDS Res Hum Retroviruses (2015)